Deaths in the 2 study groups
| Cause of death . | Study group . | |
|---|---|---|
| FAMP (total deaths = 22) . | CAP (total deaths = 22) . | |
| Toxicity during treatment | 1 | 1 |
| High-grade lymphoma | 3 | 2 |
| Secondary AML/MDS | 4 | 2 |
| Infection | 2 | 0 |
| Disease progression | 8 | 14 |
| Other | 4 | 1 |
| Unknown | 0 | 2 |
| Cause of death . | Study group . | |
|---|---|---|
| FAMP (total deaths = 22) . | CAP (total deaths = 22) . | |
| Toxicity during treatment | 1 | 1 |
| High-grade lymphoma | 3 | 2 |
| Secondary AML/MDS | 4 | 2 |
| Infection | 2 | 0 |
| Disease progression | 8 | 14 |
| Other | 4 | 1 |
| Unknown | 0 | 2 |
Values are number of deaths.
AML/MDS indicates acute myeloid leukemia/myelodysplastic syndrome.